Soleno Therapeutics (SLNO)
(Delayed Data from NSDQ)
$52.73 USD
-0.82 (-1.53%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $52.66 -0.07 (-0.13%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.61 |
EPS Last Quarter | -0.57 |
Last EPS Surprise | 9.52% |
ABR | 1.00 |
Earnings ESP
|
7.82% |
---|---|
Current Year | -2.28 |
Next Year | -2.27 |
EPS (TTM) | -2.44 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 26.71M |
# of Estimates | NA | NA | NA | 4 |
High Estimate | NA | NA | NA | 36.70M |
Low Estimate | NA | NA | NA | 17.36M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.61 | -0.62 | -2.28 | -2.27 |
# of Estimates | 4 | 4 | 5 | 4 |
Most Recent Consensus | -0.56 | -0.60 | -2.33 | -2.32 |
High Estimate | -0.56 | -0.59 | -1.87 | -2.01 |
Low Estimate | -0.65 | -0.66 | -2.47 | -2.39 |
Year ago EPS | -0.95 | -0.33 | -2.36 | -2.28 |
Year over Year Growth Est. | 35.79% | -87.88% | 3.39% | 0.61% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 2 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.61 | -0.62 | -2.28 | -2.27 |
7 Days Ago | -0.61 | -0.62 | -2.28 | -2.27 |
30 Days Ago | -0.62 | -0.63 | -2.27 | -2.25 |
60 Days Ago | -0.65 | -0.67 | -2.36 | -2.42 |
90 Days Ago | -0.65 | -0.67 | -2.36 | -2.42 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.56 | -0.60 | -2.33 | -2.32 |
Zacks Consensus Estimate | -0.61 | -0.62 | -2.28 | -2.27 |
Earnings ESP | 7.82% | 3.23% | -2.01% | -2.20% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.57 | -0.59 | -0.33 | -0.95 | NA |
Estimate | -0.63 | -0.30 | -0.31 | -0.62 | NA |
Difference | 0.06 | -0.29 | -0.02 | -0.33 | -0.15 |
Surprise | 9.52% | -96.67% | -6.45% | -53.23% | -36.71% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more